EU Approves First Biologic for Severe Uncontrolled Asthma
Tezspire is the first and only biologic approved in the EU for patients with severe asthma with no phenotype or biomarker limitations.
Source: medscape.com
Stay updated with breaking news from Guy Brusselle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tezspire is the first and only biologic approved in the EU for patients with severe asthma with no phenotype or biomarker limitations.
Tezspire is a maintenance therapy for patients with no phenotype or biomarker limitations - News - PharmaTimes
A large, international database study provides further evidence that age of asthma onset influences exacerbations and comorbidities.